Bladder Cancer Trial, Recruiting NCT06281080 Sponsor: Chinese University of Hong Kong Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06281080
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years
  • People with a body mass index (a measure of body weight relative to height) below 35
  • People with a bladder tumour smaller than 3 cm that has not grown into the deep muscle wall of the bladder
  • People whose doctor has determined that an en-bloc resection (a surgical technique to remove the tumour in one piece) is the appropriate procedure
  • People who are willing to participate and have signed a consent form

Who may not be able to join:

  • People whose scans or camera examinations show signs that the tumour has grown into the deep muscle layer of the bladder
  • People who are unable to safely receive a general or spinal anaesthetic
  • People whose overall health status is rated above a certain level on a standard medical fitness scale called the ASA classification (confirm with trial site)
  • People with a serious ongoing illness that significantly shortens life expectancy or makes surgical treatment higher risk
  • People with an active infection that has not been treated
  • People with a blood clotting problem that has not been corrected
  • People who have another cancer or cancer that has spread to other parts of the body
  • People who need emergency surgery
  • People in vulnerable groups, such as those with an intellectual disability or who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chi Fai NG, MD, Chinese University of Hong Kong

Phone: 35052625

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 November 2024
Est. completion
31 December 2025

Where this trial is recruiting

Hong Kong

Primary endpoints

Successful en-bloc tumour resection by the robotic system

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov